🔮 Other🏢 Hybrid💼 Full Time🔥 Hot1h ago
Director, Value, Access & Pricing- US Rare Tumors (TGCT)
$167,000-$230,000/year
Sign in to unlock your personalized workspace. Upgrade and view full role details.
Role Details
About the company: the company, a healthcare company of Merck KGaA, Darmstadt, Germany, is a commercial-stage biopharmaceutical company dedicated to improving the lives of patients with rare tumors. We developed and…